deltatrials

DIABETES MELLITUS TYPE 2 Trials in wŏnju, south korea

Conditions / DIABETES MELLITUS TYPE 2 / wŏnju, south korea

DIABETES MELLITUS TYPE 2 is a medical condition with active clinical research programs worldwide.

26 total trials for this combination

Showing top 10 of 26 trials

Trials

NCT ID Title Status Phase
NCT01131676 BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). COMPLETED PHASE3
NCT01991795 A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus COMPLETED PHASE3
NCT01289990 Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes COMPLETED PHASE3
NCT01042769 A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus COMPLETED PHASE3
NCT01989754 A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus COMPLETED PHASE4
NCT01243424 CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes COMPLETED PHASE3
NCT01897532 Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) COMPLETED PHASE4
NCT03268005 Research Study Comparing a New Medicine Fast-acting Insulin Aspart to Another Already Available Medicine NovoRapid/NovoLog in People With Type 2 Diabetes COMPLETED PHASE3
NCT07064473 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease RECRUITING PHASE3
NCT05352815 A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec COMPLETED PHASE3

Related Pages